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The structure of a serpin–protease complex revealed by
intramolecular distance measurements using donor–donor
energy migration and mapping of interaction sites
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Lennart B-Å Johansson2 and Tor Ny1*
Background: The inhibitors that belong to the serpin family are widely distributed
regulatory molecules that include most protease inhibitors found in blood. It is
generally thought that serpin inhibition involves reactive-centre cleavage, loop
insertion and protease translocation, but different models of the serpin–protease
complex have been proposed. In the absence of a spatial structure of a
serpin–protease complex, a detailed understanding of serpin inhibition and the
character of the virtually irreversible complex have remained controversial. 
Results: We used a recently developed method for making precise distance
measurements, based on donor–donor energy migration (DDEM), to accurately
triangulate the position of the protease urokinase-type plasminogen activator (uPA)
in complex with the serpin plasminogen activator inhibitor type 1 (PAI-1). The
distances from residue 344 (P3) in the reactive-centre loop of PAI-1 to residues
185, 266, 313 and 347 (P1′) were determined. Modelling of the complex using
this distance information unequivocally placed residue 344 in a position at the
distal end from the initial docking site with the reactive-centre loop fully inserted
into β sheet A. To validate the model, seven single cysteine substitution mutants of
PAI-1 were used to map sites of protease–inhibitor interaction by fluorescence
depolarisation measurements of fluorophores attached to these residues and
cross-linking using a sulphydryl-specific cross-linker.
Conclusions: The data clearly demonstrate that serpin inhibition involves
reactive-centre cleavage followed by full-loop insertion whereby the covalently
linked protease is translocated from one pole of the inhibitor to the opposite one.
Introduction
The inhibitors that belong to the serine protease inhibitor
(serpin) family are widely distributed in eukaryotes and
include most proteinase inhibitors that control the major
proteolytic cascades in humans [1]. Because spatial struc-
tures of stable serpin–protease complexes are unavailable,
the mechanism whereby serpins inhibit serine proteases is
controversial [2,3]. The inhibitory mechanisms of the so-
called standard-mechanism inhibitors have been exten-
sively studied [4]. These inhibitors are smaller than the
serpins and have their reactive-centre loops in a preformed
‘canonical conformation’ that matches and tightly binds to
the active-site cleft of cognate serine proteases. However,
neither the protease nor the inhibitor undergoes any major
conformational change during complex formation and the
eventual reactive-centre cleavage is reversible. 
Serpins are larger than standard-mechanism inhibitors and
are clearly distinct at a functional level [1,2]. Serpins are
thought to act by presenting their reactive centre (the
cleaveable P1–P1′ bond) as an ideal substrate to the target
protease. After the initial interaction, however, the
enzyme fails to complete the proteolytic reaction, and the
two molecules become irreversibly locked in a stable
complex [2,3]. In intact serpins, the reactive centre that
acts as a ‘bait’ for recognition by target proteases is part of
an exposed, approximately 20 amino acid long peptide
loop (the reactive-centre loop) localised above the core of
the protein [5–7]. Cleavage of the P1–P1′ bond by a non-
target protease results in the insertion of the reactive-
centre loop into β sheet A of the serpin, whereby the P1
and P1′ residues become located at opposite ends of the
serpin molecule separated by approximately 70 Å [8].
As structural information on serpin–protease complexes is
not available, the conformation of the stable complex has
been a matter for speculation. Several different models
were proposed: a model where the reactive-centre loop is
intact and the protease is located at the position of the
initial attack on the top of the serpin molecule; a model
where the loop is cleaved and partially inserts and the
covalently linked protease is translocated to a position at
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the side of the serpin molecule; and a model where the
loop is cleaved and fully inserts with the covalently linked
protease being translocated from one pole of the inhibitor
to the opposite one [9–13]. 
Recent studies have shown that a major conformational
change seems to be an important feature of the serpin
inhibitory mechanism, and in the resulting inhibitory
complex the protease is covalently attached to the serpin
P1 residue [14–17]. Furthermore, evidence exists to show
that structural changes take place within the protease
molecule and its reactive centre, which may abrogate the
catalytic activity of the protease [18–20]. Many investiga-
tors, including ourselves [21–26], have hypothesized that
insertion of the inhibitor’s reactive-centre loop into
β sheet A is an essential feature of the inhibitory mecha-
nism of serpins and this hypothesis is supported by
several recent studies [11,13,27].
As conformational changes that include loop insertion and
protease translocation seem to be an essential part of
serpin inhibition, structural information on the serpin–pro-
tease complex is crucial for a detailed understanding of
the final step leading to the formation of the virtually irre-
versible complex. To obtain the structural insights
required to discriminate between existing models of
serpin inhibition [9–13], we have studied the native cova-
lent complex between serpin plasminogen activator
inhibitor type 1 (PAI-1) and its cognate protease uroki-
nase-type plasminogen activator (uPA). The exact location
of the reactive centre in relation to four residues in the
PAI-1 part of the complex was determined by intramolec-
ular distance measurements using donor–donor energy
migration (DDEM) [28,29]. In addition, fluorescence
spectroscopy and chemical cross-linking techniques were
used to map sites of protease–inhibitor interaction. Taken
together, our structural data strongly suggest an inhibitory
mechanism in which the reactive-centre loop is fully
inserted into β sheet A and the protease is translocated
from the initial docking site to a position at the opposite
pole of the serpin. 
Results and discussion
Structural analysis of the serpin–protease complex by DDEM
Intramolecular distance measurements obtained using flu-
orescence spectroscopic methods can be very useful in
examining overall shapes and structural changes in pro-
teins, especially in the absence of spatial structures deter-
mined by X-ray crystallography and nuclear magnetic
resonance (NMR) spectroscopic methods. Electronic
energy transfer between a donor and an acceptor molecule
can be used to measure distances in a macromolecule [30].
In practice, however, this method is very difficult to use as
it requires specific attachment of one donor and one
acceptor molecule within the same macromolecule. The
complications of specific labelling are circumvented by a
recently developed method based on the site-directed
introduction of two identical fluorophore molecules into a
protein molecule and the use of DDEM for distance mea-
surements [28,29]. DDEM has the same physical origin as
the donor–acceptor energy-transfer method. Because
DDEM is a reversible process, however, it is necessary to
perform fluorescence depolarisation experiments to
monitor DDEM [28]. In a recent study of latent PAI-1 this
method was shown to give distances that are in very good
agreement with distances determined from the known
crystal structure of latent PAI-1 [7,29]. In this study we
have taken advantage of the lack of cysteine residues in
PAI-1 and introduced one or two cysteine residues at spe-
cific positions in the PAI-1 molecule for attachment of a
sulphydryl-specific derivative of fluorophore BODIPY.
Intramolecular distances between two fluorophores
attached to PAI-1 were measured by the DDEM method.
Previous studies have shown that serpin inhibition involves
a major conformational change of the inhibitor molecule in
which the protease, which is covalently attached to the
reactive-centre P1 residue, is translocated away from the
position of the initial attack [11,13,15,16]. The P3 residue
(residue 344) is present in the reactive centre of PAI-1
adjacent to the P1 residue (residue 346) to which uPA is
attached in the complex [17]. A precise location of the P3
residue in the uPA–PAI-1 complex would therefore reveal
the extent of reactive-loop insertion and the position of the
target protease in the complex. To precisely locate the
reactive centre of PAI-1 in relation to other residues in the
uPA–PAI-1 complex, we set out to determine intramolecu-
lar distances between fluorophores attached to residue 344
and PAI-1 residues 185, 266, 313 and 347 (P1′) by the
DDEM method. For this purpose, four double-cysteine
substitution mutants (S344C/M347C, S344C/H185C,
S344C/M266C, S344C/E313C; in single-letter amino acid
code) and the corresponding single mutants were labelled
with the fluorophore BODIPY. The BODIPY-labelled
mutants were found to have biochemical characteristics
that are very similar to those of wild-type PAI-1 (data not
shown). The labelled mutants were as active as wild-type
PAI-1 and rapidly formed complexes with cognate pro-
teases. The complexes formed between uPA and labelled
mutants were purified. The time-resolved fluorescence
anisotropy was determined for all the above complexes and
the data are summarised in Table 1. 
Because the DDEM between residue 344 and 313 is too
fast to be resolved, the distance cannot be precisely deter-
mined except that it must be shorter than 30 Å [29].
However, the distances between residue 344 and residues
185, 266 and 347 could be precisely determined. With
access to these three distances, it was possible to accu-
rately locate the position of the reactive centre of PAI-1 in
the complex by triangulation. Modelling of the complex
using the program Insight II (Molecular Simulation Inc.)
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and employing the distance information from Table 1 as
constraints, unequivocally placed residue 344 in a position
at the distal end from the initial docking site with the
reactive-centre loop fully inserted into β sheet A
(Figure 1a). Because the P1 residue of PAI-1 is covalently
linked to the protease’s active-centre serine residue, the
only structure of the complex compatible with the
observed distance measurements places the covalently
linked uPA at the bottom of the inhibitor (Figure 1b).
Fluorescence anisotropy to map sites of protease–inhibitor
interaction
To validate our model of the uPA–PAI-1 complex, time-
resolved fluorescence spectroscopy was used to assess the
proximity of uPA to PAI-1 in the complex. For that
purpose, seven single-cysteine mutants of PAI-1 were
created for attachment of the fluorophore BODIPY
(Figure 2a). Experiments were then performed to deter-
mine the fluorescence anisotropy of fluorophores attached
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Figure 1
Model of the uPA–PAI-1 complex based on
intramolecular distance measurements.
(a) The structure of PAI-1 (green ribbon, with
the reactive-centre loop marked in red) with
residues involved in the measurement of
intramolecular distances marked by balls and
numbered. (b) Proposed structure of the
covalent complex between PAI-1 (green
ribbon) and uPA (blue ribbon). Coordinates
for cleaved PAI-1 were a generous gift from
PJ Declerck and HL De-Bondt [35] and
coordinates for the catalytic chain of uPA
were obtained from the Brookhaven Protein
Data Bank (accession code 1LMW).
Table 1
Intramolecular distances in the PAI-1–uPA complex determined by DDEM.
System rs* φ (ns)* r(0)* ρ0† r(t∞)‡ Sj§ Sδ§ ω (×10–9s–1)# <κ2>¶ R (Å)
S344C 0.343 18.8 ± 3.5 0.362 0.28 0.86
M266C 0.300 8.1 ± 1.0 0.353 0.22 0.77
S344C/M266C 0.266 0.359 0.35 0.161 –0.12 0.42 ± 0.02 0.82 52 ± 3
S344C 0.343 18.8 ± 3.5 0.362 0.28 0.86
H185C 0.295 10.2 ± 1.5 0.347 0.20 0.74
S344C/H185C 0.247 0.355 0.38 0.140 –0.19 0.51 ± 0.2 0.94 52 ± 4
S344C 0.343 18.8 ± 3.5 0.362 0.28 0.86
M347C 0.269 6.2 ± 1.0 0.347 0.19 0.72
S344C/M347C 0.237 0.358 0.60 0.150 0.27 0.36 ± 0.1 1.64 60 ± 3
S344C 0.343 18.8 ± 3.5 0.362 0.28 0.86
E313C 0.339 16.6 ± 1.0 0.358 0.28 0.87
S344C/E313C 0.183 0.358 –0.03 0.159 0.08 >10 1.40 <30
*The fluorescence steady-state anisotropy, the rotational correlation
time and the initial anisotropy are denoted by rs, φ and r(0), respectively.
†ρ0 is a function of second and fourth rank order parameters [28]; ‡r(t∞)
is the residual anisotropy. §Sj (= 〈D00(2)(βj)〉) [28] and Sδ, denote a
second rank order parameter and the projection between effective
symmetry axes of the two orientation distributions, respectively. #ω is
the rate of DDEM. ¶<κ2> is the squared orientation average of the
dipole–dipole coupling and R is the distance between the centre of
mass of the interacting BODIPY fluorophores. Errors are based on
averages over three to four independent preparations and experiments. 
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to different positions in the PAI-1 molecule. From these
measurements the rotational rate and the orientational
freedom of the BODIPY moiety were determined.
These parameters are influenced by changes of the
microenvironment in the surroundings of the fluorophore.
In particular the orientational freedom, which can be
interpreted as a cone angle (βc) by a simplified physical
model [25], reflects the extent to which the probe is
restricted in its rotational movement by sterical hin-
drance. A reduction of the orientational freedom of
BODIPY (decreasing βc value) attached to a specific
residue following complex formation would indicate that
the probe has become sterically hindered, either by the
proximity of the target protease or by local conformational
changes in the PAI-1 molecule.
The PAI-1 single-cysteine mutants were expressed, puri-
fied and labelled with the BODIPY fluorophore
[25,31–33]. The labelled mutants were found to have very
similar biochemical characteristics to those of wild-type
PAI-1 and stable complexes could be formed between all
of the labelled PAI-1 mutants and uPA (data not shown).
The steady-state and time-resolved fluorescence anisotropy
of the BODIPY probe attached to various cysteine
mutants of active PAI-1 and PAI-1 in complex with uPA
were determined. As shown in Table 2 and Figure 2b, the
orientational freedom of BODIPY attached to all seven
cysteine residues in the PAI-1 mutants appeared to be
affected to some extent upon complex formation with
uPA. When BODIPY was attached to residues 266, 185,
154 and 301, however, the changes were less dramatic,
suggesting that only minor changes in the microenviron-
ment around these residues took place during complex
formation. For these residues, the changes were of the
same magnitude as previously observed for BODIPY
attached to the reactive centre of PAI-1 when cofactors
such as vitronectin and heparin bind to their respective
binding sites [25]. These variations are probably caused by
minor conformational changes that take place in different
parts of the PAI-1 molecule when the reactive-centre loop
inserts into β sheet A.
The most dramatic effect after complex formation was
seen for BODIPY attached to residues 159 and 313, both
of which are located at the distal end of PAI-1 from the
initial docking site for uPA. For these residues, the reduc-
tion of the orientational freedom was 41% and 50%,
respectively. For BODIPY attached to residue 147 the
orientational freedom was also reduced following complex
formation, but by only 17%. To test whether the reduction
of the orientational freedom of BODIPY attached to
these three residues was caused by the proximity of the
target protease or by local conformational changes con-
comitant with the insertion of the reactive-centre loop, we
determined the orientational freedom of BODIPY in
reactive-centre-cleaved PAI-1. As shown in Table 2 and
Figure 2b, the orientational freedom of BODIPY
attached to residue 147 was the same in cleaved PAI-1 as
in the uPA–PAI-1 complex. Therefore the change of the
microenvironment around this residue is probably caused
by conformational changes in PAI-1 and not by the prox-
imity of the target protease. For BODIPY attached to
residues 159 and 313, however, the orientational freedom
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Figure 2
Fluorescence anisotropy to map sites of protease—inhibitor interaction.
(a) Cα trace of the PAI-1 structure showing the attachment sites for
the fluorescent probe. The attachment sites are marked by red balls
and numbered. (b) The orientational freedom of the fluorophore
BODIPY, when attached to various PAI-1 residues, represented by
the cone angle (βc). Values are shown for three forms of PAI-1: the
active form (red), PAI-1 in complex with uPA (blue) and reactive-centre-
cleaved (green). (The coordinates for the model of active PAI-1 were a
generous gift from PJ Declerck and HL De-Bondt [36].)
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was very similar for active and reactive-centre-cleaved
PAI-1, suggesting that the dramatic reduction of the orien-
tational freedom observed upon complex formation is due
to steric hindrance caused by the proximity of uPA.
Chemical cross-linking to locate uPA in the uPA–PAI-1
complex
The protease uPA consists of an N-terminal noncatalytic A
chain and a C-terminal catalytic B chain linked by disul-
phide bonds. To further map the interaction sites of the
serpin–protease complex, we used a cross-linking method
to determine the proximity of uPA and PAI-1. The sul-
phydryl specific cross-linker TFPAM-6 was first attached
to the seven single-cysteine substitution mutants
(Figure 2a) and homogeneous complexes between
TFPAM-6-labelled PAI-1 and uPA were formed and cross-
linked using UV radiation. Analysis of the cross-linked
complexes by sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS–PAGE) under reducing conditions
followed by western blot analysis using a monoclonal anti-
body against the A chain of uPA, revealed that none of the
PAI-1 mutants were cross-linked to this part of the uPA
molecule (data not shown). This observation  indicates that
the noncatalytic A chain of uPA is not close enough to be
reached by the cross-linker from any of those positions. To
determine if the catalytic B chain of uPA was cross-linked
to the serpin mutants, the complexes were incubated with
1 M NH4OH to dissociate the acyl–enzyme bond between
the P1 arginine of PAI-1 and the active serine of uPA. If
the catalytic domain of uPA and PAI-1 is still covalently
connected after this treatment, it will indicate that the
cross-linker is close enough to couple to the catalytic chain
of uPA from that specific position in the PAI-1 molecule.
As shown in Figure 3, the complexes were not resistant to
alkaline hydrolysis when the cross-linker was attached to
PAI-1 residues 266, 185 and 147, indicating that the cross-
linker could not connect to the catalytic chain of uPA from
these residues. When the cross-linker was attached to
residues 154, 159, 313 and 301, however, the complexes
did not dissociate after alkaline hydrolysis indicating that
these residues are close enough to the catalytic chain of
uPA to be reached by the approximately 20 Å long cross-
linker arm. As shown in Figure 3, the complexes between
uPA and PAI-1 with the cross-linker attached to residues
154 and 159 were not homogeneous after cross-linking, and
most of the material migrated to a position corresponding
to a somewhat higher molecular weight than complexes
formed between uPA and the other PAI-1 mutants. None
of these bands were recognised by monoclonal antibodies
against the A chain of uPA (data not shown). We therefore
isolated the upper bands and performed N-terminal
sequence analysis. Only sequences corresponding to PAI-1
and the catalytic chain of uPA were found in an approxi-
mate ratio of 1:1. The differences in migration are probably
an SDS–PAGE artefact caused by incomplete unfolding of
the cross-linked complexes.
Model of the serpin–protease complex
In a previous study from this laboratory, a single distance
measurement and bifunctional chemical cross-linking
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Table 2
Steady-state and time-resolved fluorescence anisotropy of BODIPY bound to active PAI-1, the uPA–PAI-1 complex, and cleaved
PAI-1.
Samples <τ>* rs† r(t)
φ (ns)‡ r(0)§ r(t
∞
)# S¶ βc (°)¥
M266C (active) 5.27 0.290 5.8 0.347 0.225 0.780 32.3
M266C–uPA 5.47 0.276 7.0 0.345 0.191 0.718 37.0
H185C (active) 5.45 0.219 7.1 0.279 0.141 0.617 44.1
H185C–uPA 5.34 0.244 5.0 0.320 0.172 0.682 39.6
M147C (active) 5.36 0.252 8.2 0.309 0.166 0.670 40.5
M147C–uPA 5.83 0.277 6.0 0.337 0.216 0.764 33.5
M147C (cleaved) 5.67 0.281 6.5 0.337 0.218 0.767 33.4
K154C (active) 5.62 0.224 5.5 0.306 0.143 0.621 43.9
K154C–uPA 5.53 0.260 6.4 0.335 0.174 0.686 39.4
Q159C (active) 5.54 0.220 5.1 0.311 0.136 0.606 44.9
Q159C–uPA 5.47 0.332 12.9 0.361 0.267 0.849 26.3
Q159C (cleaved) 5.54 0.232 5.7 0.323 0.137 0.608 44.7
E313C (active) 5.50 0.244 7.5 0.316 0.154 0.645 44.2
E313C–uPA 5.76 0.356 28.9 0.381 0.295 0.893 22.1
E313C (cleaved) 5.63 0.256 6.4 0.329 0.173 0.684 39.5
Q301C (active) 5.51 0.230 6.2 0.299 0.152 0.639 42.6
Q301C–uPA 5.63 0.272 6.7 0.336 0.195 0.725 36.5
*<τ>, the mean fluorescence lifetime. †rs, steady-state fluorescence anisotropy. ‡φ, rotational correlation time (ns). §r(0), initial fluorescence
anisotropy. #r(t
∞
), residual fluorescence anisotropy. ¶S ( = 〈D00(2)(β)〉), the second rank order parameter. ¥βc, is the cone angle calculated from
S = ½(1 + cosβc)cosβc.
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were used to study the serpin–protease complex and a
model in which the reactive-centre loop is partially
inserted was proposed [11]. The single distance constraint
used in defining the previous model is fully compatible
with the model proposed here. However, the chemical
cross-linking data in the previous study were only consis-
tent with partial-loop insertion. Several lines of evidence
from the present study suggest that the previous partial-
loop insertion model cannot be correct. The orientational
freedom of BODIPY is dramatically reduced due to the
proximity of the protease when attached to residues 313
and 159, but not when attached to residues 147 and 154.
The catalytic domain of uPA can be cross-linked from
residues 301 and 313 located at the bottom of the serpin
but not from residue 147 located at the top of helix F.
More importantly, the distances between residue P3 and
residues P1′, 266, 185 and 313 in the complex gave struc-
tural details that support the full-loop insertion model and
exclude the partial-loop insertion model. We cannot
explain how the chemical cross-linking results in the pre-
vious study could lead to a different structural conclusion.
One possible explanation is that the cross-linked complex
was not homogeneous and that the analysed material was
not representative of the structure of the normal complex.
In the previous cross-linking experiment, we used a large
heterobifunctional cross-linker that was attached to free
NH2 groups in the cognate protease uPA and elastase
before complexes were formed. Because elastase and the
catalytic chain of uPA contain four and seven free NH2
groups, respectively, several copies of the cross-linker
were attached per protease molecule. Thus, another
explanation for the different results could be that several
large cross-linkers were attached per protease molecule,
abrogating the movement of the protease to the bottom of
the serpin. In the present study, a more compact sul-
phydryl-specific cross-linker that was attached in a single
copy at a single position in the PAI-1 molecule was used;
the cross-linker was therefore less likely to interfere with
protease translocation. Moreover, this experimental design
allows the proximity between uPA and PAI-1 to be more
precisely determined.
In the present study, we used three independent methods
to precisely determine the location of the target protease in
the stable serpin–protease complex. The results from all
three methods are consistent and reveal that the protease is
juxtapositioned at the bottom of the serpin in the immedi-
ate vicinity of residues 159 and 313. Furthermore, as deter-
mined by accurate triangulation, the reactive-centre loop is
fully inserted. Our results therefore provide the experimen-
tal evidence for the model of Wright and Scarsdale [12].
This model, which suggests that serpin inhibition involves
full-loop insertion and translocation of the target protease
from one pole of the inhibitor to the opposite one, explains
why proteases of different sizes and shapes are kinetically
trapped by forming a common type of complex with
serpins that abrogate their catalytic activity. As shown here
for the complex between uPA and PAI-1 (Figure 1b), inhi-
bition may be induced by a compression of the protease
when it is juxtapositioned against the bottom of the serpin
and the covalently attached reactive-centre loop is fully
stretched. Separate evidence for the proposed model of the
stable serpin–protease complex comes from a recent study
by Stratikos and Gettins [13]. In this study, the complex between
the naturally occurring Pittsburgh mutant of α1-protease
inhibitor and trypsin was analyzed by fluorescence tech-
niques. On the basis of fluorescence perturbations and dis-
tance estimations, a model of the complex was proposed
that is consistent with the present one. Studies of Stratikos
and Gettins using different serpin–protease pairs, together
with the present accurate triangulation of the protease in
the uPA–PAI-1 complex, suggest that the model is likely to
be generally true for serpin–protease pairs where the pro-
tease is irreversibly inhibited.
Biological implications
The inhibitors that belong to the serpin family are widely
distributed regulatory molecules that include most pro-
teinase inhibitors that control the major proteolytic cas-
cades in humans. All serpins share a common molecular
architecture based on a dominant β sheet A and have
reactive centres with a cleavable P1–P1′ bond. This
bond is located in an exposed approximately 20 amino
acid long peptide loop localised above the core of the
protein. Serpins act by presenting their reactive centre
as an ideal substrate to the target protease. After the
initial interaction, however, the enzyme fails to complete
the proteolytic reaction and the two molecules becomes
irreversibly locked in a stable complex. In the absence of
a spatial structure of a serpin–protease complex, the
final step of inhibition and the character of the virtually
irreversible complex have remained controversial.
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Figure 3
Cross-linking of uPA to the cross-linker TFPAM-6 attached to different
positions on PAI-1. The cross-linking reaction, SDS–PAGE and
western blot analysis using antihuman uPA antibody were performed
as described in the Materials and methods section. For each mutant,
the uPA–PAI-1 complexes before (–) and after (+) treatment with 1 M
NH4OH are shown. Migration of the uPA–PAI-1 complex and free uPA
(both in reduced forms) are indicated.
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To obtain structural insights into the inhibitory mecha-
nism of serpins we used a recently developed method for
making precise distance measurements, based on
donor–donor energy migration (DDEM), to measure
several intramolecular distances and thereby accurately
triangulate the position of the protease in relation to
other residues in the complex. To validate the model, the
proximity of the protease and serpin was determined by
chemical cross-linking and by measurements of the rota-
tional freedom of fluorescent probes attached to the
serpin. 
The data clearly demonstrate that the protease in the
covalent serpin–protease complex is localised at the
distal end of the serpin, more than 60 Å from the initial
docking site. This observation indicates that serpin inhi-
bition involves reactive-centre cleavage followed by full
loop insertion whereby the covalently linked protease is
translocated from one pole of the inhibitor to the oppo-
site one. Our results support the model of Wright and
Scarsdale that explains how proteases of widely differ-
ent size and composition can form a common type of
complex with serpins that abrogate their catalytic activ-
ity. As shown here, inhibition may be induced by a com-
pression of the protease when it is juxtapositioned
against the bottom of the serpin molecule and the reac-
tive-centre loop is fully stretched.
Materials and methods
Materials 
Mutagenesis primers were ordered from Pharmacia Biotech (Uppsala,
Sweden). Fluorescent labelling reagents N-(4,4-difluoro-5,7-dimethyl-4-
bora-3a,4a-diaza-s-indacene-3-propionyl)-N′-iodoacetylethylenediamine)
(BODIPY FL IA), (N-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-
indacene-3yl)methyl)iodoacetamide (BODIPY FL C1-IA), and the
cross-linking reagent N-(4-azido-2,3,5,6,-tetrafluorobenzyl)-6-6-maleimidyl
hexanamide (TFPAM-6) were obtained from Molecular Probes Inc.
(Eugene, OR, USA). NAP series desalting columns, HiTrap Heparin
(1 ml) columns and Sephacryl S-100 were from Pharmacia Biotech
(Uppsala, Sweden). The BCA* Protein Assay Reagents and SuperSig-
nal Chemiluminescent Substrate were purchased from Pierce (Rock-
ford, IL, USA). Dithiothreitol (DTT) and Tween 80 were from Sigma
(Saint Louis, MO, USA). uPA (Ukidan) was from Serono SA
(Aubonne, Switzerland). The goat antihuman uPA antibody was
obtained from Biopool (Umeå, Sweden) and the horse radish peroxi-
dase (HRP)-conjugated antigoat immunoglobulin from rabbit was
obtained from DAKO A/S, Denmark. 
Construction, expression and purification of PAI-1 cysteine
mutants 
Site-directed mutagenesis of PAI-1 was performed using a
QuickChange site-directed mutagenesis kit from Stratagene (La
Jolla, CA, USA). The plasmid pDL06 [31] containing wild-type human
PAI-1 cDNA was used as the template DNA for single-cysteine sub-
stitution during mutagenesis. Double-cysteine mutants were created
in a similar manner, based on the plasmid encoding cDNA of a single-
cysteine mutant S344C [32]. Positive clones were selected for each
mutant and PAI-1 cDNA fully sequenced using an ABI PRISM 310
genetic analyzer (Perkin Elmer) to ensure the accuracy of mutagene-
sis. Constructs were transformed into Escherichia coli strain
SG20043lon– for the expression of active PAI-1 [31]. All the cysteine
mutants were purified to homogeneity by the method of Kvassman
and Shore [33].
Preparation of PAI-1 cysteine mutants labelled with
fluorescent probes 
A PAI-1 cysteine mutant (0.1–0.2 mgml–1) was first incubated with
50 mM DTT at room temperature for 20 min to activate the thiol group
and the DTT was removed afterwards by gel filtration on a NAP-25
column equilibrated with phosphate-buffered saline (PBS), pH 7.2. The
fluorophore, either BODIPY FL IA or BODIPY FL C1-IA, was then
added immediately in 20 times molar excess to the PAI-1 cysteine
mutant in PBS containing 5% DMSO and the labelling reaction pro-
ceeded at 4°C for 12 h. The long-linker fluorophore BODIPY FL IA was
used for detecting orientational freedom and the short-linker BODIPY
FL C1-IA was used for distance measurement. Labelled PAI-1 mutants
were purified from excess of the fluorophore through NAP-25 columns
equilibrated with 100 mM phosphate buffer (pH 5.6) with 0.01% Tween
80 and were filtered using 0.45 µm filters (Millipore or Sartorius, capac-
ity 1–10 ml) to remove precipitated aggregates. The labelling efficiency
of PAI-1 was calculated as the molar ratio of the fluorophore over cys-
teines in labelled PAI-1 cysteine mutants. The molar concentration of the
fluorophore was derived from the optical density at a wavelength of
505 nm using BODIPY’s molar absorptivity 80,000 M–1cm–1 and the
concentration of PAI-1 was determined using BCA* protein assay
reagents. For double-cysteine mutants involved in distance measure-
ments, more precise determination of labelling efficiency was performed
using an API single quadrupole mass spectrometer (Sciex, Perkin-
Elmer) on which the PAI-1 molecules labelled with single fluorophore
and those with double fluorophores can be separated and quantified.
The incorporation efficiencies of fluorophores to PAI-1 double mutants
S344C/M347C, S344C/H185C, S344C/M266C and S344C/E313C
were 90%, 76%, 96% and 92%, respectively.
Preparation of the pure PAI-1 and uPA complex
Approximately 0.5 mg of each labelled PAI-1 cysteine mutant was
mixed with uPA (Ukidan, Serono, Switzerland) at a molar ratio of 1:1.2
for 20 min at room temperature. The mixture was loaded onto a 1 ml
HiTrap heparin–sepharose column (Pharmacia Biotech) equilibrated
with 100 mM phosphate buffer, pH 5.6 and 0.01% Tween 80 and
eluted into 1–2 ml by the same buffer containing 1 M NaCl. The con-
centrated mixture was subjected to a Sephacryl S-100 column
(1.5 × 80 cm) (Pharmacia Biotech) equilibrated with PBS (pH 7.4) at a
flowrate of 7.5 ml h–1. After gel filtration, the complex-containing frac-
tions were detected by SDS–PAGE and pooled before enrichment
using the HiTrap heparin column as described above. 
Fluorescence measurements
The fluorescence spectra and steady-state anisotropies were deter-
mined by a SPEX fluorolog 112 instrument equipped with Glan-
Thompson polarisers. The excitation and emission band widths were
set to 5.6 and 2.8 nm, respectively.
The single-photon counting experiments were performed on a PRA 3000
system (Photophysical Research Ass. Inc., Ontario, Canada). The excita-
tion source was a thyratron-gated flash lamp (model 510C, PRA) filled
with deuterium gas and operated at ≈ 30 kHz. The excitation and emis-
sion wavelengths were selected by interference filters (Omega/Saven
AB, Sweden) centred at 500 nm (HBW = 12.1 nm) and 550 nm
(HBW = 40 nm), respectively. The instrument response function was
determined with a light scattering solution (LUDOX). Further details of
the fluorescence depolarisation experiments are given elsewhere [28].
Data analysis
Fluorescence depolarisation experiments were obtained for two labelled
single mutants and the corresponding labelled double mutant. The
analysis of data was performed in two steps. Firstly, the fluorescence
anisotropy was analysed (see Equation 1b) for the single mutants
(j = 1,2). For each mutant this yields a rotational correlation time (φj) and
an effective order parameter (Sj). These properties were used as fixed
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parameters in the second step, where the double mutant was analysed.
The values of ρ0, Sδ and ρ(t) in Equation 1a remain variable, as the frac-
tions of labelling (fj) are known from independent experiments. The
quality of the fit was judged by the weighted residual, and by the statisti-
cal parameters of χ2 and Durbin–Watson. Acceptable χ2 values range
from 0.9 to 1.2, and the Durbin–Watson parameter should exceed 1.7.
Further details of the analysis of data are given elsewhere [28]. Typical
results obtained by fitting Equation 1 to a set of two labelled single and
one labelled double mutant is exemplified in Figure 4.
Theoretical model
The most important equations used in the analysis of fluorescence
anisotropy data are summarised below. A more elaborate presentation is
given elsewhere [28]. The time-resolved fluorescence anisotropy decay
[r(t)] of a partly labelled protein, is described by Equation 1a below:
r(t) = ½[r1(t) + r2(t)]ρ(t){1– f1–f2} + f1r1(t) + f2r2(t) +
½ r0[(ρ0–S1S2Sδ){exp(–t/φ1) + exp(–t/φ2)} + 2S1S2Sδ]{1–ρ(t)}{1–f1–f2}
(1a)
rj(t) = r0[(σj–S j
2)exp(–t/φj) + S j2 (1b)
In Equation 1a, the molar fraction of BODIPY-labelled cysteine mutant
is denoted by fj. The subscript j ( = 1 and 2), refers to numbering of the
two BODIPY molecules. The local orientation order of the BODIPY
group is described by an effective order parameter (Sj, where
–½ ≤ Sj ≤ 1, j = 1 and 2). The parameter Sδ = (3cos2δ–1)/2, describes
the projection between effective symmetry axes of the two orientation
distributions. The parameter ρ0 describes the maximum contribution to
the fluorescence anisotropy from secondary excited donor molecules,
that is donors excited through energy migration. The rotational correla-
tion times of the BODIPY molecules are denoted by φj, and the limit-
ing anisotropy, r0 = 0.370 for the BODIPY fluorophore [28]. The
fluorescence anisotropy decay of a BODIPY-labelled single mutant is
described by Equation 1b. In addition to rotation motions on the
nanosecond timescale, fast motions of probe molecules, such as libra-
tional motions may occur. Because these are usually beyond the time-
resolution of a measurement, the initial fluorescence decay is reduced
and one finds that r(0) < r0. This contribution is accounted for by the
parameter σj in Equation 1b.
The probability that the excitation is located on the initially excited
donor at a time t after excitation, is denoted by ρ(t) and is related to the
rate of DDEM (ω) according to:
ρ(t) = ½{1 + exp(–2ωt)} (2)
Equation 2 is the first-order cumulant approximation of the extended
Förster theory of energy migration [34]. Moreover, for the systems
considered here
(3a)
(3b)
Here τ, R and R0 denote the fluorescence lifetime, the distance
between the centre of mass of interacting BODIPY molecules, and
the Förster radius, respectively. For BODIPY, R0 = 57 ± 1 Å [28].
Cross-linking of the uPA–PAI-1 complex
The single PAI-1 cysteine mutants (0.1–0.2 mg ml–1) were preincu-
bated in 0.5 ml with 50 mM DTT for 20 min at room temperature to
activate the sulphydryl group. DTT was then removed using a desalting
column (NAP-5) equilibrated with PBS. The activated PAI-1 cysteine
mutants were labelled in darkness with 100 µM sulphydryl-specific
cross-linker TFPAM-6 for 1 h at room temperature. Excessive TFPAM-6
was removed using a desalting column (NAP-10) before a 1.2 M
excess of uPA was added to the labelled PAI-1 to form the uPA–PAI-1
complex. The cross-linking reaction was carried out using UV irradia-
tion for 20 min at room temperature in a 1.5 ml eppendorf tube at a dis-
tance of 2.5 cm from a Universal UV lamp (CAMAG, Switzerland). After
cross-linking, half of the complex sample was incubated with 1 M
NH4OH at room temperature for 16 h. Both NH4OH-treated and
untreated complexes were subjected to 10% SDS–PAGE under
reducing conditions followed by western blot analysis using either a
goat polyclonal antibody against human uPA or a monoclonal antibody
against the A chain of uPA (American Diagnostica Inc., USA).
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